The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies

C Chakraborty, AR Sharma, M Bhattacharya… - Frontiers in …, 2021‏ - frontiersin.org
SARS-CoV-2 has spread across the globe in no time. In the beginning, people suffered due
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …

Drug repurposing using real-world data

GSQ Tan, EK Sloan, P Lambert, CMJ Kirkpatrick… - Drug discovery today, 2023‏ - Elsevier
Highlights•250 records, including 144 original studies, met the eligibility criteria for inclusion
in this review.•Studies evaluated repurposing mainly for cardiovascular disease, COVID-19 …

Effectiveness of Drug repurposing and natural products against SARS-CoV-2: a comprehensive review

PA Velásquez, JC Hernandez, E Galeano… - Clinical …, 2024‏ - Taylor & Francis
Abstract The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a
betacoronavirus responsible for the COVID-19 pandemic, causing respiratory disorders, and …

New drug discovery

B Yingngam - Multidisciplinary Applications of Natural Science for …, 2023‏ - igi-global.com
The field of drug discovery is continually advancing with the emergence of new technologies
and scientific developments. Moreover, there is a recent growing interest in exploiting …

Structure-based drug design of RdRp inhibitors against SARS-CoV-2

K Shehzadi, A Saba, M Yu, J Liang - Topics in Current Chemistry, 2023‏ - Springer
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …

Pharmacoinformatics-based phytochemical screening for anticancer impacts of yellow sweet clover, Melilotus officinalis (Linn.) Pall

S Parvizpour, Y Masoudi-Sobhanzadeh… - Computers in Biology …, 2021‏ - Elsevier
To date, much attention has been paid to phytochemicals because of their diverse
pharmacological effects on a variety of diseases such as cancer. In this regard, computer …

Drug repurposing against SARS-CoV-2 using computational approaches

S Kumar, S Kovalenko, S Bhardwaj, A Sethi… - Drug Discovery …, 2022‏ - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
generated a critical need for treatments to reduce morbidity and mortality associated with …

Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against RNA-Dependent RNA Polymerase Complex (nsp7/nsp8/nsp12) of SARS-CoV-2

SAG Naidu, G Mustafa, RA Clemens… - Journal of Dietary …, 2023‏ - Taylor & Francis
The emergence of fast-spreading SARS-CoV-2 mutants has sparked a new phase of COVID-
19 pandemic. There is a dire necessity for antivirals targeting highly conserved genomic …

A comprehensive update on CIDO: the community-based coronavirus infectious disease ontology

Y He, H Yu, A Huffman, AY Lin, DA Natale… - Journal of biomedical …, 2022‏ - Springer
Background The current COVID-19 pandemic and the previous SARS/MERS outbreaks of
2003 and 2012 have resulted in a series of major global public health crises. We argue that …

MEDIATE-Molecular DockIng at homE: Turning collaborative simulations into therapeutic solutions

G Vistoli, C Manelfi, C Talarico, A Fava… - Expert Opinion on …, 2023‏ - Taylor & Francis
Introduction Collaborative computing has attracted great interest, enabling researchers
worldwide to come together and work seamlessly. Its relevance has never been so apparent …